tiprankstipranks
Theravance Biopharma (TBPH)
NASDAQ:TBPH
US Market
TBPH
Theravance Biopharma
RESEARCH TOOLSreports
Want to see TBPH full AI Analyst Report?

Theravance Biopharma (TBPH) Ratios

353 Followers

Theravance Biopharma Ratios

TBPH's free cash flow for Q4 2025 was $1.53. For the 2025 fiscal year, TBPH's free cash flow was decreased by $ and operating cash flow was $0.38. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 10.93 10.93 5.02 5.39 12.31
Quick Ratio
 10.93 10.93 5.02 5.39 12.31
Cash Ratio
 4.38 4.38 1.18 1.60 10.38
Solvency Ratio
 0.58 0.59 -0.30 -0.31 5.28
Operating Cash Flow Ratio
 6.23 6.23 -0.36 -1.09 -6.51
Short-Term Operating Cash Flow Coverage
 21.79 21.79 0.00 0.00 0.00
Net Current Asset Value
$ 229.61M$ 229.61M$ -17.55M$ -35.46M$ 187.86M
Leverage Ratios
Debt-to-Assets Ratio
 0.16 0.16 0.14 0.13 0.09
Debt-to-Equity Ratio
 0.25 0.25 0.28 0.23 0.12
Debt-to-Capital Ratio
 0.20 0.20 0.22 0.19 0.11
Long-Term Debt-to-Capital Ratio
 0.10 0.10 0.00 0.00 0.00
Financial Leverage Ratio
 1.64 1.64 2.02 1.79 1.37
Debt Service Coverage Ratio
 -1.68 -2.32 -19.74 -24.50 -11.95
Interest Coverage Ratio
 -5.38 -5.38 -18.44 -23.84 -14.44
Debt to Market Cap
 0.05 0.05 0.00 0.00 0.00
Interest Debt Per Share
 1.53 1.55 1.07 0.93 0.80
Net Debt to EBITDA
 -111.62 11.94 -0.31 -0.19 3.23
Profitability Margins
Gross Profit Margin
94.87%94.87%100.00%29.26%-23.46%
EBIT Margin
-1.78%-12.33%-65.34%-93.43%-154.09%
EBITDA Margin
0.77%-7.19%-59.73%-89.94%-148.18%
Operating Profit Margin
-12.33%-12.33%-72.92%-97.58%-179.09%
Pretax Profit Margin
120.27%120.27%-69.30%-85.80%-180.76%
Net Profit Margin
98.54%98.54%-87.63%-96.11%1698.54%
Continuous Operations Profit Margin
98.54%98.54%-87.63%-96.11%-180.78%
Net Income Per EBT
81.93%81.93%126.46%112.02%-939.65%
EBT Per EBIT
-975.75%-975.74%95.03%87.93%100.93%
Return on Assets (ROA)
21.81%21.81%-15.93%-14.45%143.58%
Return on Equity (ROE)
46.03%35.69%-32.14%-25.91%197.40%
Return on Capital Employed (ROCE)
-2.96%-2.96%-14.58%-15.69%-15.89%
Return on Invested Capital (ROIC)
-2.37%-2.37%-14.11%-15.52%-15.71%
Return on Tangible Assets
21.81%21.81%-15.93%-14.45%143.58%
Earnings Yield
12.49%11.25%-12.27%-8.88%105.62%
Efficiency Ratios
Receivables Turnover
 1.12 1.12 0.94 3.29 3.06
Payables Turnover
 2.15 2.15 0.00 26.65 40.79
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 3.55 3.55 1.80 1.27 0.99
Asset Turnover
 0.22 0.22 0.18 0.15 0.08
Working Capital Turnover Ratio
 0.31 0.42 0.54 0.26 0.20
Cash Conversion Cycle
 154.54 154.54 388.01 97.37 110.37
Days of Sales Outstanding
 324.50 324.50 388.01 111.07 119.32
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 169.96 169.96 0.00 13.69 8.95
Operating Cycle
 324.50 324.50 388.01 111.07 119.32
Cash Flow Ratios
Operating Cash Flow Per Share
 4.69 4.74 -0.24 -0.49 -2.54
Free Cash Flow Per Share
 4.69 4.74 -0.24 -0.53 -2.55
CapEx Per Share
 <0.01 <0.01 <0.01 0.04 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.03 1.09 1.00
Dividend Paid and CapEx Coverage Ratio
 5.68K 5.68K -34.74 -10.85 -326.91
Capital Expenditure Coverage Ratio
 5.68K 5.68K -34.74 -10.85 -326.91
Operating Cash Flow Coverage Ratio
 3.16 3.16 -0.23 -0.55 -3.58
Operating Cash Flow to Sales Ratio
 2.22 2.22 -0.18 -0.47 -3.64
Free Cash Flow Yield
27.78%25.33%-2.58%-4.74%-22.72%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 8.04 8.89 -8.15 -11.26 0.95
Price-to-Sales (P/S) Ratio
 8.02 8.76 7.14 10.82 16.08
Price-to-Book (P/B) Ratio
 2.87 3.17 2.62 2.92 1.87
Price-to-Free Cash Flow (P/FCF) Ratio
 3.61 3.95 -38.73 -21.08 -4.40
Price-to-Operating Cash Flow Ratio
 3.57 3.95 -39.85 -23.02 -4.42
Price-to-Earnings Growth (PEG) Ratio
 <0.01 -0.03 -0.54 0.55 -0.02
Price-to-Fair Value
 2.87 3.17 2.62 2.92 1.87
Enterprise Value Multiple
 930.69 -109.83 -12.27 -12.22 -7.62
Enterprise Value
 766.08M 849.12M 471.67M 631.22M 579.68M
EV to EBITDA
 926.33 -109.83 -12.27 -12.22 -7.62
EV to Sales
 7.13 7.90 7.33 10.99 11.29
EV to Free Cash Flow
 3.21 3.56 -39.75 -21.41 -3.09
EV to Operating Cash Flow
 3.21 3.56 -40.89 -23.38 -3.10
Tangible Book Value Per Share
 5.83 5.90 3.59 3.85 6.00
Shareholders’ Equity Per Share
 5.83 5.90 3.59 3.85 6.00
Tax and Other Ratios
Effective Tax Rate
 0.18 0.18 -0.26 -0.12 >-0.01
Revenue Per Share
 2.11 2.14 1.32 1.04 0.70
Net Income Per Share
 2.08 2.10 -1.15 -1.00 11.85
Tax Burden
 0.82 0.82 1.26 1.12 -9.40
Interest Burden
 -67.67 -9.76 1.06 0.92 1.17
Research & Development to Revenue
 0.35 0.35 0.58 0.81 1.36
SG&A to Revenue
 0.17 0.69 1.07 1.14 1.15
Stock-Based Compensation to Revenue
 0.17 0.17 0.33 0.44 0.77
Income Quality
 2.25 2.25 0.20 0.49 2.01
Currency in USD